1. Home
  2. NGNE vs ISSC Comparison

NGNE vs ISSC Comparison

Compare NGNE & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGNE
  • ISSC
  • Stock Information
  • Founded
  • NGNE 2003
  • ISSC 1988
  • Country
  • NGNE United States
  • ISSC United States
  • Employees
  • NGNE N/A
  • ISSC N/A
  • Industry
  • NGNE Biotechnology: Pharmaceutical Preparations
  • ISSC EDP Services
  • Sector
  • NGNE Health Care
  • ISSC Technology
  • Exchange
  • NGNE Nasdaq
  • ISSC Nasdaq
  • Market Cap
  • NGNE 325.3M
  • ISSC 257.9M
  • IPO Year
  • NGNE N/A
  • ISSC 2000
  • Fundamental
  • Price
  • NGNE $22.72
  • ISSC $15.47
  • Analyst Decision
  • NGNE Strong Buy
  • ISSC
  • Analyst Count
  • NGNE 7
  • ISSC 0
  • Target Price
  • NGNE $41.86
  • ISSC N/A
  • AVG Volume (30 Days)
  • NGNE 216.3K
  • ISSC 563.3K
  • Earning Date
  • NGNE 08-08-2025
  • ISSC 08-08-2025
  • Dividend Yield
  • NGNE N/A
  • ISSC N/A
  • EPS Growth
  • NGNE N/A
  • ISSC 68.61
  • EPS
  • NGNE N/A
  • ISSC 0.61
  • Revenue
  • NGNE $925,000.00
  • ISSC $65,055,384.00
  • Revenue This Year
  • NGNE N/A
  • ISSC $49.65
  • Revenue Next Year
  • NGNE N/A
  • ISSC $18.61
  • P/E Ratio
  • NGNE N/A
  • ISSC $25.35
  • Revenue Growth
  • NGNE N/A
  • ISSC 58.67
  • 52 Week Low
  • NGNE $6.88
  • ISSC $5.30
  • 52 Week High
  • NGNE $74.49
  • ISSC $16.82
  • Technical
  • Relative Strength Index (RSI)
  • NGNE 60.64
  • ISSC 65.91
  • Support Level
  • NGNE $20.80
  • ISSC $14.90
  • Resistance Level
  • NGNE $23.88
  • ISSC $16.12
  • Average True Range (ATR)
  • NGNE 1.44
  • ISSC 0.84
  • MACD
  • NGNE 0.09
  • ISSC -0.05
  • Stochastic Oscillator
  • NGNE 72.83
  • ISSC 66.91

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: